Physiological Effect: Reversed Anticoagulation Activity
✉ Email this page to a colleague
Drugs with Physiological Effect: Reversed Anticoagulation Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | VITAMIN K1 | phytonadione | INJECTABLE;INJECTION | 087955-001 | Jul 25, 1983 | AB1 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hospira | VITAMIN K1 | phytonadione | INJECTABLE;INJECTION | 087954-001 | Jul 25, 1983 | BP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | PROTAMINE SULFATE | protamine sulfate | SOLUTION;INTRAVENOUS | 089454-001 | Apr 7, 1987 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | PROTAMINE SULFATE | protamine sulfate | SOLUTION;INTRAVENOUS | 089454-002 | Apr 7, 1987 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Amneal | PHYTONADIONE | phytonadione | INJECTABLE;INJECTION | 216601-001 | Nov 4, 2025 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Amneal Pharms Co | PHYTONADIONE | phytonadione | TABLET;ORAL | 209373-001 | May 11, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
